atenolol has been researched along with Adenocarcinoma, Basal Cell in 2 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coelho, M | 1 |
| Moz, M | 1 |
| Correia, G | 1 |
| Teixeira, A | 1 |
| Medeiros, R | 1 |
| Ribeiro, L | 1 |
| Shin, VY | 1 |
| Wu, WK | 1 |
| Chu, KM | 1 |
| Koo, MW | 1 |
| Wong, HP | 1 |
| Lam, EK | 1 |
| Tai, EK | 1 |
| Cho, CH | 1 |
2 other studies available for atenolol and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Antiproliferative effects of β-blockers on human colorectal cancer cells.
Topics: Adenocarcinoma; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Atenolol; Carbazoles; Carvedi | 2015 |
Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells.
Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Atenolol; Butadienes; Cell Line, Tumor; Cell Proliferat | 2007 |